JWH-193
Synthetic naphthoylindole, CB1 agonist (IC50 2.8 nM in binding, rat); in France it falls under the generic clause on indol-3-yl methanones (literal reading).
Harm-reduction warning
No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.
C₂₆H₂₆N₂O₂
CAS 133438-58-1
- Family
- Synthetic CB receptor agonistNew psychoactive substance
- Molar mass
- 398.50 g/mol
Updated on
In plain terms
JWH-193 is a synthetic cannabinoid with no botanical link to hemp. In laboratory assays on rat brain membranes it binds very strongly to the CB1 receptor, the target of THC. No study in humans was found, no dose is known, and in France it falls under the narcotics list through a generic clause, on a literal reading of the text.
Receptors and activity
Target network
- Activates
The lower the cited value, the closer the target sits to JWH-193: one ring per factor of 100. A target with no measured value stays on the edge.
Where these targets live
Where each target has been found in humans, according to the cited studies. The map shows the target, not an effect of JWH-193.
CB1CB1 found in 7 regions of the body
- Basal gangliadenseMost dense in basal ganglia outflow nuclei1
- CerebellumdenseVery dense in the cerebellum1
- HippocampusdenseVery high concentrations in the hippocampus2
- AmygdaladenseHigh concentrations in the amygdala2
- CortexpresentPresent throughout the neocortex2
- Adipose tissuepresentExpressed in adipose tissue3
- GutpresentColonic epithelium, smooth muscle and plexus4
Map sources
- Herkenham M et al. Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A, 1990 (new tab)
- Glass M et al. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience, 1997 (new tab)
- Engeli S et al. Activation of the peripheral endocannabinoid system in human obesity. Diabetes, 2005 (new tab)
- Wright K et al. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology, 2005 (new tab)
Cited values
- CB1AgonistIC50 = 3.6 nM · mouse74 out of 100
Eissenstat et al., J Med Chem 1995 (values read in ChEMBL, document CHEMBL1128746) (new tab) · inhibition of electrically evoked contractions of the mouse vas deferens (assay used to distinguish agonists from antagonists); binding: IC50 of 2.8 nM, [3H]WIN 55212-2 displacement, rat brain; values read in ChEMBL (document CHEMBL1128746)
Pharmacology
JWH-193 is a synthetic naphthoylindole of the aminoalkylindole family, whose structure combines an indole core, a ketone linked to a naphthalene methylated at position 4 and a morpholinoethyl chain on the indole nitrogen, like JWH-200. Aminoalkylindoles were described by Sanofi Winthrop (Eissenstat et al. 1995) as cannabinoid receptor ligands, the key elements being a naphthyl at position 3, a small substituent at position 2 and a morpholinoethyl at position 1; according to ChEMBL, JWH-193 inhibits [3H]WIN 55212-2 binding to rat brain CB1 with an IC50 of 2.8 nM and mouse vas deferens contractions with an IC50 of 3.6 nM. Huffman and Padgett (2005) recall that the aminoalkyl group of this series can be replaced by an alkyl chain without loss of affinity. Zangani et al. (2020) place JWH-193 in category 2a of their survey of synthetic cannabinoids. No efficacy data of its own at CB2, no pharmacokinetics, metabolism or toxicology was found for this compound, and no study in humans.
Key sources.
- Eissenstat MA et al. Aminoalkylindoles: structure-activity relationships of novel cannabinoid mimetics. J Med Chem, 1995 (new tab)PMID 7636873
- Huffman JW, Padgett LW. Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes. Curr Med Chem, 2005 (new tab)PMID 15974991
- Zangani C et al. The e-Psychonauts' 'Spiced' World; Assessment of the Synthetic Cannabinoids' Information Available Online. Curr Neuropharmacol, 2020 (new tab)PMID 32116194
- PubChem, JWH-193, CID 10250276 (identifiers and properties) (new tab)
History
- Source
- An entirely synthetic compound with no natural occurrence. Zangani et al. (2020) place it in category 2a of their survey of synthetic cannabinoids: neither listed by the EUDA nor by the UNODC, but scheduled in at least one jurisdiction and/or with evidence of abuse in peer-reviewed papers, and discussed on psychonaut sites.
Origin
Laboratory synthesis
No biological pathway: JWH-193 is a synthetic compound of the naphthoylindole class, not described in any living organism.
Legal framework
- European Union
The substance is not listed in the Annex to Council Framework Decision 2004/757/JHA (consolidated version of 12 January 2026), which lists the new psychoactive substances controlled at European Union level; control is a matter for national law. It is not listed in the schedules of the 1971 Convention on Psychotropic Substances (INCB Green List, 36th edition, 2025, text reviewed). Zangani et al. (2020) place it outside the EUDA and UNODC lists of reported synthetic cannabinoids, in category 2a.
- France
JWH-193 is not named in the ANSM consolidated list of narcotics (updated 16/02/2026), which names other naphthoylindoles including JWH-200. On a literal reading of the generic family "indol-3-yl methanone" in annex IV (substituent on the indole nitrogen of the 2-(4-morpholinyl)ethyl type; naphthyl-type group, substituted or not, on the methanone bridge carbon), it falls within the clause: this is a reading of the text, not a named entry. The clause on tetrahydrocannabinols (annex III since the decision of 6 February 2026) does not apply to this naphthoylindole.
Sources: EUR-Lex, UNODC, CND, ANSM, IUPHAR/BPS, ChEBI, EUDA. Our method.
Classification
Family, origin and source verification
- Family
Synthetic CB receptor agonist › New psychoactive substance
- Class
naphthoylindole
- Verification
Classification, sources and binding values checked on 20 October 2026; text read against its sources and Wikipedia.
- Wikipedia (English)
Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.
References
- Eissenstat MA et al. Aminoalkylindoles: structure-activity relationships of novel cannabinoid mimetics. J Med Chem, 1995 (new tab)PMID 7636873
- Huffman JW, Padgett LW. Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes. Curr Med Chem, 2005 (new tab)PMID 15974991
- Zangani C et al. The e-Psychonauts' 'Spiced' World; Assessment of the Synthetic Cannabinoids' Information Available Online. Curr Neuropharmacol, 2020 (new tab)PMID 32116194
- PubChem, JWH-193, CID 10250276 (identifiers and properties) (new tab)
Identifiers
Names
- IUPAC name
- (4-methylnaphthalen-1-yl)-[1-(2-morpholin-4-ylethyl)indol-3-yl]methanone
Identifiers
- Formula
- C₂₆H₂₆N₂O₂
- CAS
- 133438-58-1
- PubChem CID
- 10250276(new tab)
- InChIKey
- ICKWPPYMDARCKJ-UHFFFAOYSA-N
- SMILES
- CC1=
CC= C(C2= CC= CC= C12) C(= O) C3= CN(C4= CC= CC= C43) CCN5CCOCC5
LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.